Testing effectiveness (Phase 2)Ended earlyNCT02473445
What this trial is testing
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
Who this might be right for
Mitochondrial Diseases
Amgen 22